Decision Dossier
Evidence package linked to RPT-0103 and DEC-0099
Key datasets + assay outcomesRisk flags + mitigation notesRole-based signoff sequence
Narrative + charts + tables with linked decision dossier and approvals. Business and scientific purpose: support timely investment and governance decisions with auditable, cross-functional scientific evidence. Report RPT-0103 is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.
Evidence package linked to RPT-0103 and DEC-0099
| id | type | rationale | approvedBy |
|---|---|---|---|
| DEC-0099 | go | risk exceeds threshold | Prof. Ben Carter |
| DEC-0131 | no-go | needs follow-up | Dr. Alice Morgan |
| DEC-0156 | hold | evidence strong | Daniel Osei |
| DEC-0228 | hold | needs follow-up | Prof. Ben Carter |